English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Boehringer Ingelheim
Robert Hadley
| Jun 28, 2017
Pradaxa study highlights need for early diagnosis of atrial fibrillation
Ruth de Jauregui
| Jun 2, 2017
Phase III trials of Ofev show positive results for idiopathic pulmonary fibrosis patients
Ruth de Jauregui
| May 31, 2017
Boehringer Ingelheim trial shows tiotropium Respimat improves breathing for asthma patients
Gene Johnson
| Mar 10, 2017
Boehringer Ingelheim, Vanderbilt University partner to expand cancer research
Carol Ostrow
| Nov 27, 2016
‘Sweetheart’ survey reveals need for health education among type 2 diabetes patients
Amanda Rupp
| Oct 2, 2016
Boehringer Ingelheim partners with ViraTherapeutics for immuno-oncology project
Amanda Rupp
| Sep 6, 2016
Experts develop largest IPF patient registry yet
Trending
+
Pharmaceuticals
Patient Daily
| Jun 18, 2025
ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+
Pharmaceuticals
Patient Daily
| Jun 16, 2025
American Consumer Institute questions hospital use of 340B Drug Pricing Program
+
Pharmaceuticals
Patient Daily
| Jun 13, 2025
Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
